참고문헌
- Sampson, H.A. Atopic dermatitis. Ann Allergy 69(6):469-479, 1992
- Daniels, J. and Harper, J. The epidemiology of atopic dermatitis. Hosp Med 63(11):649-652, 2002 https://doi.org/10.12968/hosp.2002.63.11.1908
- Leung, D.Y. and Soter, N.A. Cellular and immunologic mechanisms in atopic dermatitis. J Am Acad Dermatol 44(1 Suppl):S1-S12, 2001 https://doi.org/10.1067/mjd.2001.109302
- Spergel, J.M., Mizoguchi, E., Oettgen, H., Bhan, A.K. and Geha, R.S. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 103(8):1103-1111, 1999 https://doi.org/10.1172/JCI5669
- Chen, L., Martinez, O., Overbergh, L., Mathieu, C., Prabhakar, B.S. and Chan, L.S. Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol 138(3):375-387, 2004 https://doi.org/10.1111/j.1365-2249.2004.02649.x
- Yawalkar, N., Uguccioni, M., Scharer, J., Braunwalder, J., Karlen, S., Dewald, B., Braathen, L.R. and Baggiolini, M. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 113(1):43-48, 1999 https://doi.org/10.1046/j.1523-1747.1999.00619.x
- Leung, D.Y. Atopic dermatitis: immunobiology and treatment with immune modulators. Clin Exp Immunol 107 Suppl 1: 25-30, 1997
- Cooper, K.D. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 102(1):128-137, 1994 https://doi.org/10.1111/1523-1747.ep12371746
- 이경미. 養血潤膚湯의 免疫 調節作用을 통한 항알러지 效能. 대전대학교대학원, 대전, 2007
- Vestergaard, C., Yoneyama, H. and Matsushima, K. The NC/Nga mouse: a model for atopic dermatitis. Mol Med Today 6(5):209-210, 2000 https://doi.org/10.1016/S1357-4310(00)01683-X
- Heishi, M., Imai, Y., Katayama, H., Hashida, R., Ito, M., Shinagawa, A. and Sugita, Y. Gene expression analysis of atopic dermatitis-like skin lesions induced in NC/Nga mice by mite antigen stimulation under specific pathogen-free conditions. Int Arch Allergy Immunol 132(4):355-363, 2003 https://doi.org/10.1159/000074903
- Robert, C. and Kupper, T.S. Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 341(24):1817-1828, 1999 https://doi.org/10.1056/NEJM199912093412407
- Vestergaard, C., Yoneyama, H., Murai, M., Nakamura, K., Tamaki, K., Terashima, Y., Imai, T., Yoshie, O., Irimura, T., Mizutani, H. and Matsushima, K. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 104(8):1097-1105, 1999 https://doi.org/10.1172/JCI7613
- Clevers, H., Alarcon, B., Wileman, T. and Terhorst, C. The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol 6: 629-662, 1988 https://doi.org/10.1146/annurev.iy.06.040188.003213
- van der Heijden, F.L., Wierenga, E.A., Bos, J.D. and Kapsenberg, M.L. High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 97(3):389-394, 1991 https://doi.org/10.1111/1523-1747.ep12480966
- Bieber, T., Rieger, A., Stingl, G., Sander, E., Wanek, P. and Strobel, I. CD69, an early activation antigen on lymphocytes, is constitutively expressed by human epidermal Langerhans cells. J Invest Dermatol 98(5):771-776, 1992 https://doi.org/10.1111/1523-1747.ep12499948
- Renz, H., Jujo, K., Bradley, K.L., Domenico, J., Gelfand, E.W. and Leung, D.Y. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J Invest Dermatol 99(4):403-408, 1992 https://doi.org/10.1111/1523-1747.ep12616114
- Lester, M.R., Hofer, M.F., Gately, M., Trumble, A. and Leung, D.Y. Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis. J Immunol 154(11):6174-6181, 1995
- Stevens, S.R., Hanifin, J.M., Hamilton, T., Tofte, S.J. and Cooper, K.D. Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels. Arch Dermatol 134(7):799-804, 1998 https://doi.org/10.1001/archderm.134.7.799
- Schneider, L.C., Baz, Z., Zarcone, C. and Zurakowski, D. Long-term therapy with recombinant interferon-gamma (rIFN-gamma) for atopic dermatitis. Ann Allergy Asthma Immunol 80(3):263-268, 1998 https://doi.org/10.1016/S1081-1206(10)62968-7
- Ma, W., Bryce, P.J., Humbles, A.A., Laouini, D., Yalcindag, A., Alenius, H., Friend, D.S., Oettgen, H.C., Gerard, C. and Geha, R.S. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest 109(5):621-628, 2002 https://doi.org/10.1172/JCI0214097